A Study In Adults With Moderate To Severe Dermatomyositis
A Study In Adults With Moderate To Severe Dermatomyositis
NCT ID: NCT03181893 Phase: PHASE2 Status: COMPLETED Enrollment: 75 Completion: 2022-11-28
Conditions
Dermatomyositis
Interventions
PF-06823859 low, Placebo Arm, PF-06823859 high
Summary
A Study looking at Investigational drug and Placebo administered to adult Patients with moderate to severe Dermatomyositis
Primary Outcome
Change From Baseline in Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) Activity Score at Week 12 (Stage 1, Stage 2 and Amended Stage 2)